Risk of subsequent primary cancers in patients with carcinoma of the Ampulla of Vater.
Affiliation
Centre for Cancer Epidemiology, University of Manchester, Christie Hospital NHS Trust, UK.Issue Date
1997
Metadata
Show full item recordAbstract
Data were collected on subsequent primary cancers occurring in 194 individuals diagnosed with ampullary carcinoma during 1979-92 in the north western region of England, UK. Four cancers were identified compared with 6.62 expected (relative risk 0.60), suggesting that individuals with ampullary carcinoma are not at increased risk of developing subsequent primary cancers.Citation
Risk of subsequent primary cancers in patients with carcinoma of the Ampulla of Vater. 1997, 76 (9):1232-3 Br. J. CancerJournal
British Journal of CancerPubMed ID
9365175Type
ArticleLanguage
enISSN
0007-0920Collections
Related articles
- Malignant neoplasms associated with cancer of the ampulla of Vater.
- Authors: Hatch EE, Curtis RE, Boice JD Jr, Fraumeni JF Jr
- Issue date: 1992 Dec
- Carcinoma of the ampulla of vater.
- Authors: Brandt-Rauf PW, Pincus MR, Adelson S
- Issue date: 1986
- Carcinoma of the ampulla of Vater synchronously associated with early gastric cancer--a report of two cases.
- Authors: Yamashita H, Higashijima H, Fukushima K, Nagai E, Makino I, Okamoto S, Kuroki S, Ichimiya H, Chijiiwa K
- Issue date: 1995 Aug
- An investigation of primary malignancies associated with ampullary carcinoma.
- Authors: Kamisawa T, Egawa N, Tsuruta K, Okamoto A, Horiguchi S, Funata N
- Issue date: 2005 Jan-Feb
- Association of ampullary and colorectal malignancies.
- Authors: Das A, Neugut AI, Cooper GS, Chak A
- Issue date: 2004 Feb 1
Related items
Showing items related by title, author, creator and subject.
-
Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future.O'Brien, M; van Meerbeeck, J; Surmont, V; Faivre-Finn, Corinne (2012)
-
Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.Ingham, S; Warwick, J; Buchan, I; Sahin, S; O'Hara, Catherine; Moran, Anthony; Howell, Anthony; Evans, D; Centre for Health Informatics, Institute of Population Health, The University of Manchester, Manchester, UK. (2013-06)Mutations in BRCA1/2 genes confer ovarian, alongside breast, cancer risk. We examined the risk of developing ovarian cancer in BRCA1/2-positive families and if this risk is extended to BRCA negative families.
-
AZD8186 study 1: phase I study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary anti-tumour activity of AZD8186 in patients with advanced castration-resistant prostate cancer (CRPC), squamous non-small cell lung cancer, triple negative breast cancer and with PTEN-deficient/mutated or PIK3CB mutated/amplified malignancies, as monotherapy and in combination with vistusertib (AZD2014) or abiraterone acetate.Lillian, S; De Bono, J; Higano, C; Shapiro, G; Brugger, W; Mitchell, P; Colebrook, S; Klinowska, T; Barry, S; Dean, Emma J; et al. (2016-12)